SEARCH

SEARCH BY CITATION

References

  • BIFULCO, M. & DI MARZO, V. (2002). Targeting the endocannabinoid system in cancer therapy: A call for further research. Nat. Med., 8, 547550.
  • BISOGNO, T., HOWELL, F., WILLIAMS, G., MINASSI, A., CASCIO, M.G., LIGRESTI, A., MATIAS, I., SCHIANO-MORIELLO, A., PAUL, P., WILLIAMS, E.-J., GANGADHARAN, U., HOBBS, C., DI MARZO, V. & DOHERTY, P. (2003). Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J. Cell Biol., 163, 463468.
  • BISOGNO, T., MELCK, D., DE PETROCELLIS, L., BOBROV, M.Y., GRETSKAYA, N.M., BEZUGLOV, V.V., SITACHITTA, N., GERWICK, W.H. & DI MARZO, V. (1998). Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase. Biochem. Biophys. Res. Comm., 248, 515522.
  • BISOGNO, T., SEPE, N., MELCK, D., MAURELLI, S., DE PETROCELLIS, L. & DI MARZO, V. (1997). Biosynthesis, release and degradation of the novel endogenous cannabimimetic metabolite 2-arachidonoylglycerol in mouse neuroblastoma cells. Biochem. J., 322, 671677.
  • BOLDRUP, L., WILSON, S.J., BARBIER, A.J. & FOWLER, C.J. (2004). A simple stopped assay for fatty acid amide hydrolase avoiding the use of a chloroform extraction phase. J. Biochem. Biophys. Methods, 60, 171177.
  • CASCIO, M.G., BISOGNO, T., MATIAS, I., DE PETROCELLIS, L., ORLANDO, P. & DI MARZO, V. (2004). Enzymes for 2-AG biosynthesis and metabolism in cell lines, and their pharmacological inhibition. 2004 Symposium on the Cannabinoids, International Cannabinoid Research Society, Berlington, Vermont, U.S.A., p. 110.
  • CHAU, L.-Y. & TAI, H.-H. (1988). Monoglyceride and diglyceride lipases from human platelet microsomes. Biochim. Biophys. Acta, 963, 436444.
  • CLEMENT, A.B., HAWKINS, E.G., LICHTMAN, A.H. & CRAVATT, B.F. (2003). Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase. J. Neurosci., 23, 39163923.
  • COMPTON, D.R. & MARTIN, B.R. (1997). The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity. J. Pharmacol. Exp. Ther., 283, 11381143.
  • CRAVATT, B.F., DEMAREST, K., PATRICELLI, M.P., BRACEY, M.H., GIANG, D.K., MARTIN, B.R. & LICHTMAN, A.H. (2001). Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. U.S.A., 98, 93719376.
  • CRAVATT, B.F., GIANG, D.K., MAYFIELD, S.P., BOGER, D.L., LERNER, R.A. & GILULA, N.B. (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature, 384, 8387.
  • CRAVATT, B.F. & LICHTMAN, A.H. (2002). The enzymatic inactivation of the fatty acid amide class of signaling lipids. Chem. Phys. Lipids, 121, 135148.
  • DASSE, O., MAHADEVAN, A., HAN, L., MARTIN, B.R., DIMARZO, V. & RAZDAN, R.K. (2000). The synthesis of N-vanillyl-arachidonoyl-amide (arvanil) and its analogs: an improved procedure for the synthesis of the key synthon methyl 14-hydroxy-(all-cis)-5,8,11,-tetradecatrienonate. Tetrahedron, 56, 91959202.
  • DE PETROCELLIS, L., CASCIO, M.G. & DI MARZO, V. (2004). The endocannabinoid system: a general view and latest additions. Br. J. Pharmacol., 141, 765774.
  • DEUTSCH, D.G. & CHIN, S.A. (1993). Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem. Pharmacol., 46, 791796.
  • DI MARZO, V., BISOGNO, T., DE PETROCELLIS, L., MELCK, D., ORLANDO, P., WAGNER, J.A. & KUNOS, G. (1999). Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur. J. Biochem., 264, 258267.
  • DI MARZO, V., BISOGNO, T., SUGIURA, T., MELCK, D. & DE PETROCELLIS, L. (1998). The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. Biochem. J., 331, 1519.
  • DINH, T.P., CARPENTER, D., LESLIE, F.M., FREUND, T.F., KATONA, I., SENSI, S.L., KATHURIA, S. & PIOMELLI, D. (2002). Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. U.S.A., 99, 1081910824.
  • EISENTHAL, R. & CORNISH-BOWDEN, A. (1974). The direct linear plot. A new graphical procedure for estimating enzyme kinetic parameters. Biochem. J., 139, 715720.
  • FEZZA, F., BISOGNO, T., MINASSI, A., APPENDINO, G., MECHOULAM, R. & DI MARZO, V. (2002). Noladin ether, a putative novel endocannabinoid: inactivation mechanisms and a sensitive method for its quantification in rat tissues. FEBS Lett., 513, 294298.
  • FOWLER, C.J. (2003). Plant-derived, synthetic and endogenous cannabinoids as neuroprotective agents. Non-psychoactive cannabinoids, ‘entourage’ compounds and inhibitors of N-acyl ethanolamine breakdown as therapeutic strategies to avoid pyschotropic effects. Brain Res. Rev., 41, 2643.
  • FOWLER, C.J. (2004). Metabolism of the endocannabinoids anandamide and 2-arachidonoyl glycerol, a review, with emphasis on the pharmacology of fatty acid amide hydrolase, a possible target for the treatment of neurodegenerative diseases and pain. Curr. Med. Chem. – Central Nervous System Agents, 4, 161174.
  • FOWLER, C.J., CALLINGHAM, B.A., O'CONNOR, M.D.L. & MATTHEWS, E.K. (1980). The effect of sonication upon monoamine oxidase-A and -B in the rat liver. Biochem. Pharmacol., 29, 11851188.
  • FOWLER, C.J., HOLT, S. & TIGER, G. (2003). Acidic non-steroidal anti-inflammatory drugs inhibit rat brain fatty acid amide hydrolase in a pH-dependent manner. J. Enzyme Inhib. Med. Chem., 18, 5558.
  • FOWLER, C.J., JONSSON, K.-O. & TIGER, G. (2001). Fatty acid amide hydrolase: biochemistry, pharmacology and therapeutic possibilities for an enzyme hydrolyzing anandamide, 2-arachidonoylglycerol, palmitoylethanolamide and oleamide. Biochem. Pharmacol., 62, 517526.
  • FOWLER, C.J., TIGER, G., LIGRESTI, A., LÓPEZ-RODRÍGUEZ, M.L. & DI MARZO, V. (2004). Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis – a difficult issue to handle. Eur. J. Pharmacol., 492, 111.
  • GERDEMAN, G.L. & LOVINGER, D.M. (2003). Emerging roles for endocannabinoids in long-term synaptic plasticity. Br. J. Pharmacol., 140, 781789.
  • GOPARAJU, S.K., UEDA, N., TANIGUCHIM, K. & YAMAMOTO, S. (1999). Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem. Pharmacol., 57, 417423.
  • GOPARAJU, S.K., UEDA, N., YAMAGUCHI, H. & YAMAMOTO, S. (1998). Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett., 422, 6973.
  • HAN, L. & RAZDAN, R.K. (1999). Total synthesis of 2-arachidonylglycerol (2-Ara-Gl). Tetrahedron Lett., 40, 16311634.
  • HANUS, L., ABU-LAFI, S., FRIDE, E., BREUER, A., VOGEL, Z., SHALEV, D.E., KUSTANOVICH, I. & MECHOULAM, R. (2001). 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc. Natl. Acad. Sci. U.S.A., 98, 36623665.
  • HARRINGTON, C.R. (1990). Lowry protein assay containing sodium dodecyl sulfate in microtiter plates for protein determination on fractions from brain tissue. Analyt. Biochem., 186, 285287.
  • HILLARD, C., WILKISON, D., EDGEMOND, W. & CAMPBELL, W. (1995). Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. Biochim. Biophys. Acta, 1257, 249256.
  • HO, S.-Y., DELGADO, L. & STORCH, J. (2002). Monoacylglycerol metabolism in human intestinal Caco-2 cells. Evidence for metabolic compartmentation and hydrolysis. J. Biol. Chem., 277, 18161823.
  • HUANG, S.M., BISOGNO, T., PETROS, T.J., CHANG, S.Y., ZAVITSANOS, P.A., ZIPKIN, R.E., SIVAKUMAR, R., COOP, A., MAEDA, D.Y., DE PETROCELLIS, L., BURSTEIN, S., DI MARZO, V. & WALKER, J.M. (2001). Identification of a new class of molecules, the arachidonoyl amino acids, and characterization of one member that inhibits pain. J. Biol. Chem., 276, 4263942644.
  • IKEDA, Y., OKAMURA, K. & FUJII, S. (1977). Purification and characterisation of rat liver microsomal monoacylglycerol lipase in comparison to the other esterases. Biochim. Biophys. Acta, 488, 128139.
  • JÁRAI, Z., WAGNER, J.A., GOPARAJU, S.K., WANG, L., RAZDAN, R.K., SUGIURA, T., ZIMMER, A.M., BONNER, T.I., ZIMMER, A. & KUNOS, G. (2000). Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Hypertension, 35, 679684.
  • KARLSSON, M., CONTRERAS, J.A., HELLMAN, U., TORNQVIST, H. & HOLM, C. (1997). cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J. Biol. Chem., 272, 2721827223.
  • KARLSSON, M., REUE, K., XIA, Y.-R., LUSIS, A.J., LANGIN, D., TORNQVIST, H. & HOLM, C. (2001). Exon–intron organization and chromosomal localization of the mouse monoglyceride lipase gene. Gene, 272, 1118.
  • KARLSSON, M., TORNQVIST, H. & HOLM, C. (2000). Expression, purification, and characterization of histidine-tagged mouse monoglyceride lipase from baculovirus-infected insect cells. Prot. Expr. Purif., 18, 286292.
  • KATHURIA, S., GAETANI, S., FEGLEY, D., VALIÑO, F., DURANTI, A., TONTINI, A., MOR, M., TARZIA, G., LA RANA, G., CALIGNANO, A., GIUSTINO, A., TATTOLI, M., PALMERY, M., CUOMO, V. & PIOMELLI, D. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat. Med., 9, 7681.
  • KIM, J. & ALGER, B. (2004). Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat. Neurosci., 7, 697698.
  • LICHTMAN, A.H., HAWKINS, E.G., GRIFFIN, G. & CRAVATT, B.F. (2002). Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J. Pharmacol. Exp. Ther., 302, 7379.
  • LIGRESTI, A., BISOGNO, T., MATIAS, I., DE PETROCELLIS, L., CASCIO, M.G., CONSENZA, V., D'ARGENIO, G., SCAGLIONE, G., BIFULCO, M., SORRENTINI, I. & DI MARZO, V. (2003). Possible endocannabinoid control of colorectal cancer growth. Gastroenterology, 125, 677687.
  • LÓPEZ-RODRÍGUEZ, M.L., VISO, A., ORTEGA-GUTIÉRREZ, S., LASTRES-BECKER, I., GONZÁLEZ, S., FERNÁNDEZ-RUIZ, J. & RAMOS, J.A. (2001). Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors. J. Med. Chem., 44, 45054508.
  • MACCARRONE, M., SALVATI, S., BARI, M. & FINAZZI-AGRÒ, A. (2000). Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. Biochem. Biophys. Res. Commun., 278, 576583.
  • MARTIN, B.R., JEFFERSON, R., WINCKLER, R., WILEY, J.L., HUFFMAN, J.W., CROCKER, P.J., SAHA, B. & RAZDAN, R.K. (1999). Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists, and antagonists. J. Pharmacol. Exp. Ther., 290, 10651079.
  • MAURELLI, S., BISOGNO, T., DE PETROCELLIS, L., LUCCIA, A.D., MARINO, G. & DI MARZO, V. (1995). Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’. FEBS Lett., 377, 8286.
  • NATARAJAN, V., SCHMID, P.C., REDDY, P.V. & SCHMID, H.H.O. (1984). Catabolism of N-acylethanolamine phospholipids by dog brain preparations. J. Neurochem., 42, 16131619.
  • NG, E.W., AUNG, M.M., ABOOD, M.E., MARTIN, B.R. & RAZDAN, R.K. (1999). Unique analogues of anandamide: arachidonoyl ethers and carbamates and norarachidonoyl carbamates and ureas. J. Med. Chem., 42, 19751981.
  • OKA, S., TSUCHIE, A., TOKUMURA, A., MURAMATSU, M., SUHARA, Y., TAKAYAMA, H., WAKU, K. & SUGIURA, T. (2003). Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. J. Neurochem., 85, 13741381.
  • OKAMOTO, Y., MORISHITA, J., TSUBOI, K., TONAI, T. & UEDA, N. (2004). Molecular characterization of a phospholipase D generating anandamide and its congeners. J. Biol. Chem., 279, 52985305.
  • OMEIR, R.L., CHIN, S., HONG, Y., AHERN, D.G. & DEUTSCH, D.G. (1995). Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase. Life Sci., 56, 19992005.
  • PERTWEE, R.G. (2001). Cannabinoid receptors and pain. Progr. Neurobiol., 63, 569611.
  • PERTWEE, R.G., GIBSON, T.M., STEVENSON, L.A., ROSS, R.A., BANNER, W.K., SAHA, B., RAZDAN, R.K. & MARTIN, B.R. (2000). O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties. Br. J. Pharmacol., 129, 15771584.
  • SAARIO, S.M., SAVINAINEN, J.R., LAITINEN, J.T., JÄRVINEN, T. & NIEMI, R. (2004). Monoglyceride lipase-like enzymatic acitivity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem. Pharmacol., 67, 13811387.
  • SAKURADA, T. & NOMA, A. (1981). Subcellular localization and some properties of monoacylglycerol lipase in rat adipocytes. J. Biochem., 90, 14131419.
  • SCHMID, P.C., ZUZARTE-AUGUSTIN, M.L. & SCHMID, H.H.O. (1985). Properties of rat liver N-acylethanolamine amidohydrolase. J. Biol. Chem., 260, 1414514149.
  • SOMMA-DELPÉRO, C., VALETTE, A., LEPETIT-THÉVENIN, J., NOBILI, O., BOYER, J. & VÉRINE, A. (1995). Purification and properties of a monoacylglycerol lipase in human erythrocytes. Biochem. J., 312, 519525.
  • SUGIURA, T., KODAKA, T., NAKANE, S., MIYASHITA, T., KONDA, S., SUHARA, Y., TAKAYAMA, H., WAKU, K., SEKI, C., BABA, N. & ISHIMA, Y. (1999). Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure–activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds. J. Biol. Chem., 274, 27942801.
  • TORNQVIST, H. & BELFRAGE, P. (1976). Purification and some properties of a monoacylglycerol-hydrolysing enzyme of rat adipose tissue. J. Biol. Chem., 251, 813819.
  • VAN DER STELT, M., VAN KUIK, J.A., BARI, M., VAN ZADELHOFF, G., LEEFLANG, B.R., VELDINK, G.A., FINAZZI-AGRÒ, A., VLIEGENTHART, J.F.G. & MACCARRONE, M. (2002). Oxygenated metabolites of anandamide and 2-arachidonoylglycerol: conformational analysis and interaction with cannabinoid receptors, membrane transporter, and fatty acid amide hydrolase. J. Med. Chem., 45, 37093720.
  • VANDEVOORDE, S., JONSSON, K.-O., FOWLER, C.J. & LAMBERT, D.M. (2003). Modifications of the ethanolamine head in N-palmitoyl-ethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide. J. Med. Chem., 46, 14401448.
  • WILEY, J.L., DEWEY, M.A., JEFFERSON, R.G., WINCKLER, R.L., BRIDGEN, D.T., WILLOUGHBY, K.A. & MARTIN, B.R. (2000). Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects. Life Sci., 67, 15731583.